Post Parker Institute for Cancer Immunotherapy Scientist Kole Roybal of UCSF Wins Inaugural Sartorius & Science Prize for Regenerative Medicine & Cell Therapy
Post The Parker Institute for Cancer Immunotherapy Appoints Immunotherapy Expert John Connolly as Chief Scientific Officer
Post BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes
Post Parker Institute for Cancer Immunotherapy Named to Top 10 List of Most Innovative Companies in Biotech by Fast Company
Post The Parker Institute for Cancer Immunotherapy Appoints Seasoned Health Care Leader Frederic Pla as Chief Operating Officer